Full text is available at the source.
Abstract
Colorectal cancer (CRC) is the third most common cause of cancer deaths worldwide.
- Circadian clocks regulate physiological functions in humans and may influence the tumor immune microenvironment (TIME) in CRC.
- Recent findings suggest that circadian components are significant regulators of the immunogenicity of CRC cells.
- Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has improved cancer treatment but requires better patient selection for effectiveness.
- There is a lack of comprehensive reviews on the relationship between circadian components, TIME, and CRC cell immunogenicity.
- This review proposes a predictive framework integrating circadian factors to enhance ICI treatment outcomes for CRC patients.
Simplified